MRI contribution to the diagnosis of breast disease;Place de l'IRM dans le diagnostic des affections mammaires

Presse Medicale

Volumn 29, Issue 20, 2000, Pages 1145-1153

  Tardif de Gery S ^a   Zagdanski, A M ^a   Merzoug, V ^a   Guermazi, A ^a   Bourrier, J ^a   De Kerviler, E ^a   Frija, J ^a  

^a SAINT LOUIS HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM;

BREAST DISEASE; BREAST RECONSTRUCTION; CANCER DIAGNOSIS; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HUMAN; HUMAN TISSUE; NUCLEAR MAGNETIC RESONANCE; REVIEW; RISK FACTOR;

BIOPSY; BREAST DISEASES; BREAST NEOPLASMS; FEMALE; GADOLINIUM; HUMANS; MAGNETIC RESONANCE IMAGING; SENSITIVITY AND SPECIFICITY;

EID: 0034631344     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (48)

1. Heywang-Köbrunner S, Beck R. Contrast-enhanced MRI of the breast. (2 ed.) Berlin, Heidelberg, New York: 1995. (Springer, ed).
2. French M. MRI of the breast: state of the art. Eur Radiology 1998 ; 8:707-25.
3. Frouge C, Guinebretière J, Di Paola R, Contesso G, Blery M. Correlation between contrast enhancement and tumor angiogenesis. Invest Radiol 1994 ; 29:1043-49.
4. Schorn C, Fischer U, Luftner-Nagel S, Grabbe E. Diagnostic potential of ultrafast contrast-enhanced MRI of the breast in hypervascularized lesions: are there advantages in comparison with standard dynamic MRI? J Comput Assist Tomogr 1999 ; 23:118-22.
5. Fisher H. Problèmes techniques posés par l'IRM du sein. J Le sein 1996 ; 6:247-51.
6. Boné B, Péntek Z, Perbeck L, Veress B. Diagnostic accuracy of mammography and contrast-enhanced MR imaging in 238 histologically verified breast lesions. Acta Radiol 1997 ; 38:489-96.
7. Buadu L, Murakami J, Murayama S et al. Patterns of peripheral enhancement in breast masses: correlation of findings on contrast medium enhanced MRI with histopathologic features and tumor angiogenesis. J Comput Assist Tomo 1997 ; 21:421-30.
8. Buckley D, Mussurakis S, Horsman A. Effect of temporal resolution on diagnostic efficacy of contrast-enhanced MRI in the conservatively treated breast. J Comput Assist Tomogr 1998 ; 22:47-51.
9. Daniel B, Jeffrey S, Birdwell R, Ikeda D, Sawyer-Glover A, Herfkens R. Three-dimensional shaded-surface rendering of MR images of the breast: technique, applications, and impact on surgical management of breast disease. Radiographics 1998 ; 18:483-96.
10. Fobben E, Rubin C, Kalisher L, Dembner A, Seltzer M, Santoro E. Breast MR imaging with commercially available techniques: radiologic-pathologic correlation. Radiology 1995 ; 196:143-52.
11. Kuhl C, Elevelt A, Leutner C, Gieseke J, Pakos E, Schild H. interventional breast MR imaging: clinical use of a stereotactic localization and biopsy device. Radiology 1997 ; 205:667-75.
12. Kvistad K, Lundgren S, Fjosne H, Smenes E, Smethurst HB, Haraldseth O. Differenciating benign and malignant breast lesions with T2*-weighted first pass perfusion imaging. Acta Radiol 1999 ; 40:45-51.
13. Gilles R, Meunier M, Lucidarme O et al. Clustered breast microcalcifications: evaluation by dynamic contrast-enhanced subtraction MRI. J Comput Assist Tomogr 1996 ; 20:9-14.
14. Liu P-F, Debatin J, Caduff R, Kacl G, Garzoli E, Krestin G. Improved diagnostic accuracy in dyanmic contrast enhanced MRI of the breast by combined quantitative and qualitative analysis. Br J Radiol 1998 ; 71:501-9.
15. Müller R-D, Barkhausen J, Sauerwein W, Langer R. Assessment of local recurrence after braest-conserving therapy with MRI. J Comput Assist Tomogr 1998 ; 22:408-12.
16. Mussurakis S, Gibbs P, Horsman A. Peripheral enhancement and spatial contrast uptake heterogeneity of primary breasttumours: quantitative assessment with dynamic MRI. J Comput Assist Tomogr 1998 ; 22:35-46.
17. Orel S, reynolds C, Schnall M, Solir L, Fraker D, Sullivan D. Breast carcinoma: MR imaging before re-excisional biopsy. Radiology 1997 ; 205:429-36.
18. Rieber A, Merkle E, Zeitler H et al. Value of MR mammography in the detection and exclusion of recurrent breast carcinoma. J Comput Assist Tomogr 1997 ; 21:780-4.
19. Rodenko G, Harms S, Pruneda J et al. MR imaging in the management before surgery of lobular carcinoma of the breast: correlation with pathology. Am J Roentgenol 1996 ; 167:1415-19.
20. Sherif H, Mahfouz A-E, Oellinger H et al. Peripheral washout sign on contrast-enhanced MR images of the breast. Radiology 1997 ; 205:209-13.
21. Soo M, Kornguth P, Walsh R et al. Intracapsular implant rupture: MR findings of incomplete shell collapse. J Magn Reson Im 1997 ; 7:724-30.
22. Soderstrom C, harms S, Farrell RJ, Pruneda J, Flamig D. Detection with MR imaging of residual tumor in the breast soon after surgery. Am J Roentgenol 1997 ; 168:485-8.
23. Mussurakis S, Buckley D, Horsman A. Dynamic MRI of invasive breast cancer: assessment of three region-of-interest analysis method. J Comput Assist Tomogr 1997 ; 21:431-8.
24. Gilles R, Cuinebretière J-M, Lucidarme O et al. Non-palpable breast tumor: diagnosis with contrast-enhanced subtraction dynamic MRI. Radiology 1994 ; 191:625-31.
25. Kuhl C, Seibert C, Kreft B, Gieseke J. Focal and diffuse contrast enhancement in healthy volunteers. Radiology 1994 ; 193:121.
26. Solomon B, Orel S, Reynolds C, Schnall M. Delayed development of enhanced in fat necrosis after breast conservation therapy: a potential pitfall of MR imaging of the breast. Am J Roentgenol 1998 ; 170:966-8.
27. Coady A, Mussurakis S, Owen A, Turnbull L. Case report: MR imaging of fat necrosis of the breast associated with lipid cyst formation following conservative treatment for breast carcinoma. Clin Radiol 1996 ; 51:815-17.
28. Beekman W, van Straalen W, Hage J, Taets von Amerongen A, Mulder J. Imaging sign and radiologist's jargon of ruptured breast implant. Plast Reconstr Surg 1998 ; 102:1281-9.
29. Gilles R, Guinebretière J-M, Toussaint C et al. Locally advanced breast cancer: contrast-enhanced subtraction MR imaging of response to preoperative chemotherapy. Radiology 1994 ; 191:633-8.
30. Rieber A, Zeitler H, Rosenthal H et al. MRI of breast cancer: influence of chemotherapy on sensitivity. Br J Radiol 1997 ; 70:452-8.
31. Orel S, Schnall M, Livolsi V, Troupin R. Suspicious breast lesions: MR imaging with radiologic-pathologic correlation. Radiology 1994 ; 190:485-93.
32. Buadu L, Murakami J, Murayama S et al. Breast lesions: correlation of contrast medium enhancement patterns on MR images with histopathologic findings and tumor angiogenesis. Radiology 1996 ; 200:639-49.
33. Weind K, Maier C, Rutt B, Moussa M. Invasive carcinomas and fibroadenomas of the breast: comparison of microvessel distributions-implications for imaging modalities. Radiology 1998 ; 208:477-83.
34. Weinstein D, Strano S, Cohen P, Fields S, Gomori J, Degani H. Breast fibroadenoma: mapping of pathophysiologic features with three-time-point, contrast-enhanced MR imaging-Pilot study. Radiology 1999 ; 210:233-40.
35. Gilles R, Zafrani B, Guinebretière JM et al. Ductal carcinoma in situ: MR imaging-histopathologic correlation. Radiology 1995 ; 196:415-19.
36. Daniel B, Yi-Fen Y, Glover G et al. Breast disease: dynamic spiral MR imaging. Radiology 1998 ; 209:499-509.
37. Buckley D, Drew P, Mussurakis S, Monson J, Horsman A. Microvessel density in invasive breast cancer assessed by dynamic Gd-DTPA enhanced MRI. J Magn Reson Im 1997 ; 7:461-4.
38. Müller-Schimpfle M, Ohmenhäuser K, Sand J, Stoll P, Claussen C. Dynamic 3D-MR mammography: is there a benefit of sophisticated evaluation of enhancement curves for clinical routine? J Magn Reson Im 1997 ; 7:236-40.
39. Soderstrom C, Harms S, Copit D et al. Three-dimensional RODEO breast MR imaging of lesions containing ductal carcinoma in situ. Radiology 1996 ; 201:427-32.
40. Greenstein Orel S, Schnall M, Powell C et al. Staging of suspected breast cancer: effect of MR imaging and MR-guided biopsy. Radiology 1995 ; 196:115-22.
41. Lawrence W, Liang W, Mandelblatt J et al. Serendipity in diagnostic imaging: magnetic resonance imaging of the breast. J Natl Cancer I 1998 ; 90:1792-800.
42. Daniel B, Birdwell R, Ikeda D, et al. Breast lesion localization: e freehand, interactive MR imaging-guided technique. Radiology 1998 ; 207:455-63.
43. Morris E, Schwartz L, Dershaw D, Van Zee K, Abramson A, Liberman L. MR imaging of the breast in patients with occult primary breast carcinoma. Radiology 1997 ; 205:437-40.
44. Douek M, Vaidya J, Lakhani S, Hall-Craggs M, Baum M, Taylor I. Can magnetic-resonance imaging help elucidate natural history of breast cancer multicentry? Lancet 1998 ; 351:801-2.
45. Douek M, Vaidya J, Baum M, Taylor I. Magnetic-resonance imaging and breast cancer multicentry. Lancet 1998 ; 352:652-3.
46. Wiberg M, Boné B, Bronge L, Aspelin P. Comparison of the contrast enhancement pattern in the two different T1-weighted 3-D sequences in MR imaging of the breast Acta Radiol 1998 ; 39:680-5.
47. Gould S, Lamb G, Lomax D, Gedroyc W, Darzi A. Interventional MR-guided excisional biopsy of breast lesions. J Magn Reson Im 1998 ; 8:26-30.
48. Mumtaz H, Hall-Craggs M, Wotherspoon A et al. Laser therapy for breast cancer: MR imaging and histopathologic correlation. Radiology 1996 ; 200:651-8.